300.17 Mechanical Thrombectomy or Catheter-Directed Lysis Versus Heparin in Treating Intermediate-Risk Pulmonary Embolism: 30-Day Outcomes
JACC: Cardiovascular Interventions · 2026-03 · 19 (5) · S37-S38
DOI: 10.1016/j.jcin.2026.01.127 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Nicolas W. Shammas und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shammas, N. W., Sharis, W., Shammas, G., & Jones-Miller, S. (2026). 300.17 Mechanical Thrombectomy or Catheter-Directed Lysis Versus Heparin in Treating Intermediate-Risk Pulmonary Embolism: 30-Day Outcomes. JACC: Cardiovascular Interventions, 19(5), S37-S38. https://doi.org/10.1016/j.jcin.2026.01.127
Vancouver
Shammas NW, Sharis W, Shammas G, Jones-Miller S. 300.17 Mechanical Thrombectomy or Catheter-Directed Lysis Versus Heparin in Treating Intermediate-Risk Pulmonary Embolism: 30-Day Outcomes. JACC: Cardiovascular Interventions. 2026;19(5):S37-S38. doi:10.1016/j.jcin.2026.01.127
BibTeX
@article{Shammas2026,
author = {Shammas, Nicolas W. and Sharis, William and Shammas, Gail and Jones-Miller, Sue},
title = {300.17 Mechanical Thrombectomy or Catheter-Directed Lysis Versus Heparin in Treating Intermediate-Risk Pulmonary Embolism: 30-Day Outcomes},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {5},
pages = {S37--S38},
doi = {10.1016/j.jcin.2026.01.127}
}
EUVIMED